ClinicalTrials.gg
RecruitingNCT07810257Updated Sep 9, 2026

Prospective Longitudinal Cohort Study of Implant Age, Pocket Plane, Incision, Surface Texture, and Volume as Predictors of Breast Implant Shell Fissure

An observational study in Breast Implant Complication and Breast Implant Shell Defect, sponsored by Research Inc. Recruiting at 1 site in Colombia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Research Inc · Observational

From the registry’s dates

  • Started Jan 2014; still recruiting 12 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,000
Ages
18 Years and older
Sex
All
01

Study summary

This prospective implant-surveillance cohort will evaluate predictors of breast implant shell fissure. Women with aesthetic implants without baseline fissure or rupture will undergo annual clinical and imaging assessment for up to five years. Implant age, pocket plane, incision route, surface texture, and volume will be evaluated as predictors. The primary outcome is time to first confirmed focal shell fissure; progression to complete rupture, symptoms, inter-reader agreement, and revision will also be assessed.

Read the detailed description

A locked radiologic and operative definition will distinguish focal shell fissure from complete rupture, deformation, porosity, and leakage. Eligible women will enter only after baseline imaging shows no shell defect. Annual ultrasound and confirmatory MRI will prospectively identify incident events, which will undergo central blinded review and surgical confirmation when available. Delayed-entry time-to-event models will evaluate implant and surgical predictors and will account for bilateral implants and competing removal. A multi-state analysis will explore progression from intact implant to fissure and rupture if the event count is adequate.

02

Conditions studied

  • Breast Implant Complication
  • Breast Implant Shell Defect

Browse trials for

Keywords

  • Breast Implant Fissure
  • Shell Integrity
  • Implant Age
  • Pocket Plane
  • Incision
  • Volume
03

In context

Surgical Wound

315 studies on the registry are indexed under Surgical Wound; 57 are open to participants now.

This study's planned enrollment of 3,000 is above the median of 72 across 51 observational studies indexed under Surgical Wound.

Browse Surgical Wound studies →

Lead sponsor

Research Inc is the lead sponsor of 24 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult women with aesthetic breast implants that are intact and without a documented shell fissure at baseline.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female sex and age 18 years or older.
  • Aesthetic breast implant with known implantation date or year and known pocket plane, incision route, surface texture, and volume.
  • No fissure or rupture identified by the baseline imaging algorithm.
  • Ability to undergo annual ultrasound and confirmatory MRI when indicated.
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Confirmed fissure or rupture at cohort entry.
  • Reconstructive breast implantation or tissue expander.
  • Immediate planned implant removal or exchange.
  • Missing core implant characteristics.
  • MRI when MRI is required to adjudicate a suspected event.
  • Recalled/PIP implant if excluded by the final analytic plan.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,000 participants (estimated)
Target follow-up
10 Years
Patient registry
Yes

Groups and cohorts

  • Implant Shell Integrity Surveillance Cohort

    Women with no baseline shell defect are followed prospectively. Implant and surgical characteristics are modeled as exposures.

    Device: Breast Implant Exposure · Diagnostic Test: Structured Implant Shell Imaging

Interventions

  • DeviceBreast Implant Exposure

    Recorded characteristics include implant age, material, surface texture, shape, volume, pocket plane, incision route, manufacturer/lot when available, primary or revision placement, and laterality. Linked arm/group(s): Implant Shell Integrity Surveillance Cohort.

  • Diagnostic testStructured Implant Shell Imaging

    Annual high-resolution ultrasound and confirmatory MRI will apply a locked definition of focal shell fissure, complete rupture, deformation, porosity, and silicone leakage. Event images will undergo blinded central review. Linked arm/group(s): Implant Shell Integrity Surveillance Cohort.

06

What researchers measure

Primary outcomes

  1. Time to First Confirmed Breast Implant Shell Fissure

    Implant-level time from cohort entry to the first focal partial-thickness or noncomplete shell discontinuity meeting the locked MRI, ultrasound, or operative criteria and not meeting the definition of complete rupture.

    Time frame: From cohort entry through years of prospective follow-up. 10 years

Secondary outcomes

  1. Fissure-Free Survival by Implant Age

    Probability of remaining free of confirmed fissure at prespecified implant ages using delayed-entry survival methods.

    Time frame: 10 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Glener AD, Sergesketter AR, Adams WP Jr. Outcomes of In-Office, High Resolution Ultrasound Silicone Breast Implant Surveillance by Plastic Surgeons. Aesthet Surg J. 2024 Dec 12;45(1):48-55. doi: 10.1093/asj/sjae165. PubMed 39054844 ↗
  • Hadad E, Klein D, Seligman Y, Wiser I, Heller L. Sub-muscular plane for augmentation mammoplasty patients increases silicone gel implant rupture rate. J Plast Reconstr Aesthet Surg. 2019 Mar;72(3):419-423. doi: 10.1016/j.bjps.2018.11.009. Epub 2018 Nov 22. PubMed 30616906 ↗

Individual participant data

Plan to share: No — not considered in the patient informed consent

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2014 to primary completion in Jan 2026, 143 months.

Of 31 observational studies under Surgical Wound, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's 143 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2026
First posted
Sep 9, 2026
StartActual
Jan 12, 2014
Primary completionActual
Jan 1, 2026
CompletionEst.
Dec 15, 2026
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07810257
Lead sponsor
Research Inc
Responsible party
Sponsor
First posted
Sep 9, 2026
Start date
Jan 12, 2014
Primary completion
Jan 1, 2026
Completion
Dec 15, 2026 (estimated)
Last update
Sep 9, 2026

Study contacts

Juan Velez, MD, Plastic surgeon
Contact
info@velezlara.com
+57 3054511588
juan velez, MD, plastic surgery
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion